Skip to main content
. 2018 Jun 22;9:1381. doi: 10.3389/fmicb.2018.01381

Table 2.

Patients with proven and probable invasive Candida infections and corresponding frequencies of Candida-reactive T cells.

Direct fungal evidence
Patient Underlying disease/Host factor Risk factor Radiological findings Beta-D-Glucan Histology Fungal culture Invasive Candida Infection EORTC grade Increased T cell frequency Cross-reactivity
1 Chronic kidney disease Mesenteric ischemia CVC Dialysis ICU Parenteral nutrition Surgery Neg. N.D. N.D. BC and TC (Peritoneum): C. glabrata BC: C. parapsilosis Candidemia Peritonitis Proven C. glabrata C. parapsilosis Neg.
2 Diabetes mellitus Pancreatic carcinoma CVC ICU Surgery Neg. N.D. N.D. BC: C. albicans Candidemia Endophthalmitis Proven C. glabrata Neg.
3 Urothelial carcinoma Surgery Neg. N.D. N.D. BC: C. albicans Candidemia Proven C. albicans Neg.
4 Chronic liver disease Colorectal carcinoma Obesity Chemotherapy Surgery Neg. N.D. N.D. BC: C. albicans Candidemia Proven C. albicans C. parapsilosis Pos.
5 Pancreatic carcinoma Obesity CVC Dialysis ICU Surgery Abdominal CT N.D. N.D. BC: C. glabrata; C. parapsilosis Candidemia Hepatosplenic Candidiasis Proven C. glabrata C. parapsilosis Neg.
6 Chronic liver disease Pancreatic carcinoma Chemotherapy CVC Radiotherapy Surgery N.D. N.D. N.D. BC: C glabrata Candidemia Proven C. glabrata Neg.
7* Burkitt-Lymphoma HIV/AIDS Rheumatic disease Chemotherapy CVC ICU Neutropenia Spinal PET/CT Spinal MRI Spinal CT Neg. Neg. BC: C. albicans TC: (Spinal disc and psoas abscess): C. albicans Candidemia Osteomyelitis Spondylodiscitis Proven C. albicans Neg.
8 Diabetes mellitus Hodgkin Lymphoma Obesity Viral pneumonia Chemotherapy CVC ICU Surgery Neg. N.D. N.D. BC: C. albicans Candidemia Proven C. albicans Neg.
9 HIV/AIDS Non-Hodgkin Lymphoma Underweight Chemotherapy CVC ICU Radiotherapy Neg. N.D. N.D. BC and CVC culture: C. albicans Catheter related bloodstream infection Candidemia Proven C. albicans Neg.
10 Alcohol addiction AML Chemotherapy CVC ICU Neutropenia Surgery Neg. N.D. N.D. BC: C. glabrata Candidemia Proven C. glabrata Neg.
11 Alcohol addiction Chronic liver disease Diabetes mellitus Underweight CVC Parental nutrition Neg. N.D. N.D. BC: C. glabrata Candidemia Proven C. glabrata Neg.
12 ALL Chemotherapy Abdominal CT, Abdominal MRI, Abdominal Ultrasound Pos. Pos. Neg. Hepatosplenic Candidiasis Proven C. albicans, C. glabrata C. parapsilosis, C. tropicalis Pos.
13 Chronic renal disease Diabetes mellitus Obesity CVC Dialysis ICU Neg. N.D. N.D. BC: C. glabrata Candidemia Proven C. glabrata Neg.
14 AML Chemotherapy Neutropenia Abdominal Ultrasound Pos. Neg. Neg. Hepatosplenic Candidiasis Probable C. glabrata Neg.

Classification of invasive Candida infections according to the 2008 EORTC/MSG criteria, culture or histology of Candida spp. and Candida-reactive T cells (De Pauw et al., 2008). Pos., positive; Neg., negative; N.D., not done; AIDS, acquired immunodeficiency syndrome; ALL, Acute lymphatic leukemia; AML, Acute myeloid leukemia; BC, blood culture; CT, Computer Tomography; CVC, central venous catheter; HIV, human immunodeficiency virus; ICU, intensive care unit; MRI, Magnetic Resonance Imaging; PET, Positron Emission Tomography; TC, tissue culture;

*

(Koehler et al., 2017).

Candida spp. causing hepatosplenic candidiasis have not been identified, cross-reactivity may represent mixed infection.